Karali Y, Karali Z, Cekic S, Cakir I, Kilic S
BMC Immunol. 2025; 26(1):22.
PMID: 40089660
DOI: 10.1186/s12865-025-00703-w.
Polat O, Orhun G, Anakli I, Yilmaz V, Koral G, Ulusoy C
In Vivo. 2025; 39(2):810-818.
PMID: 40010959
PMC: 11884498.
DOI: 10.21873/invivo.13883.
Li H, Chen X, Wang J, Shen J, Abuduwufuer K, Zhang Z
Signal Transduct Target Ther. 2025; 10(1):59.
PMID: 39924580
PMC: 11808084.
DOI: 10.1038/s41392-025-02143-9.
Mai C, Fukui A, Saeki S, Takeyama R, Yamaya A, Shibahara H
Reprod Med Biol. 2025; 24(1):e12610.
PMID: 39807425
PMC: 11725765.
DOI: 10.1002/rmb2.12610.
Bondarenko N, Lifantseva N, Voronova S, Melnikova V
Int J Mol Sci. 2025; 25(24.
PMID: 39769295
PMC: 11677199.
DOI: 10.3390/ijms252413532.
Anti-NMDAR encephalitis presenting with persistent fever and meningitis and responding well to distinctive individualized first-line treatment: A case report.
Jin X, Zhuang J, Xu J
Medicine (Baltimore). 2024; 103(49):e40803.
PMID: 39654216
PMC: 11630919.
DOI: 10.1097/MD.0000000000040803.
Intravenous Immunoglobulin Therapy for Pyoderma Gangrenosum: A Multicenter Retrospective Analysis in 81 Patients.
Ronicke M, Sollfrank L, Vitus M, Walter L, Krieter M, Moelleken M
Am J Clin Dermatol. 2024; 26(1):139-146.
PMID: 39541069
PMC: 11741994.
DOI: 10.1007/s40257-024-00904-w.
IVIG response in pediatric acute-onset neuropsychiatric syndrome correlates with reduction in pro-inflammatory monocytes and neuropsychiatric measures.
Melamed I, Rahman S, Pein H, Heffron M, Frankovich J, Kreuwel H
Front Immunol. 2024; 15:1383973.
PMID: 39421743
PMC: 11484259.
DOI: 10.3389/fimmu.2024.1383973.
Role of immune cells in the establishment of implantation and maintenance of pregnancy and immunomodulatory therapies for patients with repeated implantation failure and recurrent pregnancy loss.
Saito S
Reprod Med Biol. 2024; 23(1):e12600.
PMID: 39091423
PMC: 11292669.
DOI: 10.1002/rmb2.12600.
Effect of intravenous immunoglobulin on mortality in hospitalized patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials.
Ramachandram D, Kow C, Hasan S, Thiruchelvam K
Health Sci Rep. 2024; 7(7):e2239.
PMID: 38983684
PMC: 11230917.
DOI: 10.1002/hsr2.2239.
Plasmapheresis and IVIG for Treatment of Non-Tumor Anti-Tr/DNER Antibody-Associated Ataxia: A Case Report.
Adibi A, Rastegar-Kashkouli A, Yousefi P, Adibi I, Ahmadi E, Naghavi S
Cerebellum. 2024; 23(5):2208-2213.
PMID: 38874737
DOI: 10.1007/s12311-024-01711-z.
Lower-dose intravenous immunoglobulin therapy for geriatric inflammatory bowel disease accompanied by COVID-19 multisystem inflammatory syndrome: A case report.
Zhang P, Chen J, Zhao W, Liu J
Medicine (Baltimore). 2024; 103(17):e37888.
PMID: 38669420
PMC: 11049714.
DOI: 10.1097/MD.0000000000037888.
Design of the STRIVE-IPF trial- study of therapeutic plasma exchange, rituximab, and intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fibrosis.
Kulkarni T, Criner G, Kass D, Rosas I, Scholand M, Dilling D
BMC Pulm Med. 2024; 24(1):143.
PMID: 38509495
PMC: 10953157.
DOI: 10.1186/s12890-024-02957-3.
Design of the STRIVE-IPF Trial- Study of Therapeutic Plasma Exchange, Rituximab, and Intravenous Immunoglobulin for Acute Exacerbations of Idiopathic Pulmonary Fibrosis.
Kulkarni T, Criner G, Kass D, Rosas I, Scholand M, Dilling D
Res Sq. 2024; .
PMID: 38464052
PMC: 10925430.
DOI: 10.21203/rs.3.rs-3962419/v1.
Intravenous immunoglobulin for patients with unexplained recurrent implantation failure: a 6-year single center retrospective review of clinical outcomes.
Peero E, Banjar S, Khoudja R, Ton-Leclerc S, Beauchamp C, Benoit J
Sci Rep. 2024; 14(1):3876.
PMID: 38365988
PMC: 10873418.
DOI: 10.1038/s41598-024-54423-z.
Mechanism underlying polyvalent IgG-induced regulatory T cell activation and its clinical application: Anti-idiotypic regulatory T cell theory for immune tolerance.
Victor J, Nahm D
Front Immunol. 2023; 14:1242860.
PMID: 38094290
PMC: 10716439.
DOI: 10.3389/fimmu.2023.1242860.
The use of intravenous immunoglobulin in the treatment of Hashimoto's encephalopathy: case based review.
Sorodoc V, Constantin M, Asaftei A, Lionte C, Ceasovschih A, Sirbu O
Front Neurol. 2023; 14:1243787.
PMID: 37745658
PMC: 10513043.
DOI: 10.3389/fneur.2023.1243787.
Serum immunoglobulin and the threshold of Fc receptor-mediated immune activation.
Bauer-Smith H, Sudol A, Beers S, Crispin M
Biochim Biophys Acta Gen Subj. 2023; 1867(11):130448.
PMID: 37652365
PMC: 11032748.
DOI: 10.1016/j.bbagen.2023.130448.
Regulatory T Cell-Targeted Immunomodulatory Therapy for Long-Term Clinical Improvement of Atopic Dermatitis: Hypotheses and Perspectives.
Nahm D
Life (Basel). 2023; 13(8).
PMID: 37629531
PMC: 10455293.
DOI: 10.3390/life13081674.
Intravenous immunoglobulins (IVIG) in severe/critical COVID-19 adult patients.
Kwapisz D, Boguslawska J
Biomed Pharmacother. 2023; 163:114851.
PMID: 37167723
PMC: 10160523.
DOI: 10.1016/j.biopha.2023.114851.
